Egr‑1 promotes the proliferation and migration of vascular smooth muscle cells by transcriptionally activating Egr‑2 in arteriovenous fistulas
International Journal of Molecular Medicine · 2025
DOI: 10.3892/ijmm.2025.5568 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Medicine, 2025. Verfasst von Ke Hu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. Chin…. Hauptthemen laut MEDLINE: Early Growth Response Protein 1, Cell Movement, Muscle, Smooth, Vascular, Early Growth Response Protein 2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Arteriovenous fistulas (AVFs) are preferred access points for hemodialysis. The present study aimed to investigate the function of early growth response‑1 (Egr‑1) in the proliferation and migration of smooth muscle cells (SMCs) and assess its potential as a new therapeutic target for AVF treatment. A comprehensive analysis combining public data‑source mining, human tissue collection, animal studies, cell culture experiments and various molecular biology techniques was conducted. The public dataset GSE119296 was used for immunohistochemical analyses of human AVF stenosis samples. SMC‑specific Egr‑1 knockout mice and various in vitro assays on primary rat vascular SMCs were used to evaluate the effect of Egr‑1 on the functional capacity of SMCs. RNA sequencing and chromatin immunoprecipitation sequencing was performed. Egr‑1 was upregulated in human AVF stenosis samples and cultured SMCs. Knockout of Egr‑1 in mice mitigated AVF outflow tract stenosis, improved flow dynamics and diminished neointima formation. In vitro, Egr‑1 ablation reduced SMC proliferation and migration; Egr‑1 transcriptionally activated Egr‑2. Increased Egr‑1 expression facilitated SMC proliferation and migration through Egr‑2 regulation, contributing to AVF stenosis. Consequently, targeting Egr‑1 may offer a novel therapeutic approach for managing AVF intimal hyperplasia and improving AVF patency and function in patients with end‑stage renal disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China.
- Department of Cardiology, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian 361006, P.R. China.
- Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430022, P.R. China.
- Department of Pharmacy, Wuhan No. 1 Hospital, Wuhan, Hubei 430022, P.R. China.
Zitieren
APA
Hu, K., Bu, S., Guo, Y., Li, Y., Yu, S., Wang, L., Cai, C., Li, Y., Liu, X., Huang, H., & Wang, W. (2025). Egr‑1 promotes the proliferation and migration of vascular smooth muscle cells by transcriptionally activating Egr‑2 in arteriovenous fistulas. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2025.5568
Vancouver
Hu K, Bu S, Guo Y, Li Y, Yu S, Wang L, et al. Egr‑1 promotes the proliferation and migration of vascular smooth muscle cells by transcriptionally activating Egr‑2 in arteriovenous fistulas. International Journal of Molecular Medicine. 2025. doi:10.3892/ijmm.2025.5568
BibTeX
@article{Hu2025,
author = {Hu, Ke and Bu, Shichen and Guo, Yi and Li, Yuxuan and Yu, Shiwen and Wang, Lulu and Cai, Chuanqi and Li, Yiqing and Liu, Xin and Huang, Hegui and Wang, Weici},
title = {Egr‑1 promotes the proliferation and migration of vascular smooth muscle cells by transcriptionally activating Egr‑2 in arteriovenous fistulas},
journal = {International Journal of Molecular Medicine},
year = {2025},
doi = {10.3892/ijmm.2025.5568}
}
EUVIMED